Satellite Banner
Technology Networks Header
Sunday, November 23, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
IDT Launches GMP MGB Eclipse® Probes for In Vitro Diagnostic Use
Tuesday, November 11, 2014
High quality, excellent service, and product transparency for human qPCR diagnostic applications.

Bio-Rad Introduces System to Automate Operation of Real-Time PCR Instruments
Monday, November 03, 2014
The CFX Automation System II automates the operation of up to two CFX Real-Time PCR Detection Systems.

Bio-Rad’s New Automated Droplet Generator
Tuesday, October 28, 2014
New AutoDG™ instrument for Droplet Digital™ PCR saves time and improves data quality.

Bio-Rad Adds New PrimePCR™ Assays for Droplet Digital™ PCR
Wednesday, October 22, 2014
This release expands Bio-Rad’s current offering of predesigned and fully wet-lab validated assays.

Bio-Rad Introduces Real-Time PCR Assays for Rat Genome
Thursday, October 09, 2014
Wet-lab validated PrimePCR™ Rat Genome Assays ensure accurate quantitative PCR results.

Mobidiag Announces CE-IVD Marking of Amplidiag™ Bacterial GE
Thursday, September 25, 2014
Test optimizes screening of gastroenteritis-causing bacteria directly from stool samples.

Tecan Offers NGS Sample Preparation at the Touch of a Button
Friday, September 19, 2014
Tecan’s Freedom EVO NGS workstation to offer robust and reliable automation.

Agilent Introduces Modular Real-Time PCR System
Friday, September 12, 2014
Instrument Provides High Resolution, Less Interference Between Channels.

Biocartis Launches Its Flagship Molecular Diagnostics Platform Idylla™
Friday, September 12, 2014
Idylla™’s first test identifies cancers driven by the BRAF oncogene. Cancer patients will benefit significantly from faster therapy decisions and better guidance of treatment choices.

<< 1 2 3 4 5 6 7 >>
Showing Results 1 - 10 of 590
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
SELECTBIO Market Reports
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv